Lactose India

Ahmedabad, India Founded: 1991 • Age: 35 yrs Listed
Pharmaceutical excipients including lactose and dosage forms are manufactured.
Request Access
Report Incorrect Data
Page last updated

About Lactose India

Lactose India is a publicly listed company based in Ahmedabad (India) founded in 1991. Pharmaceutical excipients including lactose and dosage forms are manufactured. It operates in the Healthcare and Consumer sectors. The company has 140 employees. Its Indian entity Lactose (India) Limited reported revenue of ₹164 Cr. Its focus areas include Life Sciences, Nutraceuticals Tech, Nutraceutical Ingredients and Functional Food Ingredients.

Company details

The company was founded in 1991 in Ahmedabad, India, and operates within the pharmaceutical sector. Excipients such as lactose monohydrate and lactulose are produced, alongside solid and liquid dosage forms. Manufacturing and supply chain services are provided in compliance with regulatory standards. Research and development efforts are focused on pharmaceutical innovations, while partnerships are maintained to support industry advancements.

  • Headquarters Ahmedabad, India
  • Employees 140
  • Stage Public
  • Sectors
    Healthcare
    Consumer
  • Email
    ••••••••
  • Website lactoseindialimited.com
  • Legal Name Lactose India Ltd.
Operational Areas
Healthcare → Nutraceutical & Food-as-Medicine Platforms
Consumer → Food Processing
Key Metrics
  • Market Cap
    ₹134 Cr

    LACTOSE · BSE

  • Share Price
    ₹104.40

    -2.02% today

  • Revenue
    ₹163 Cr

    FY 2025-26 · +40.3% YoY

  • EBITDA
    ₹18.38 Cr

    Margin 11.3%

  • Net Profit
    ₹6.06 Cr

    FY 2025-26 · +18.1% YoY

  • P/E (TTM)
    18.6x

    P/B 2.2x

  • Employee Count
    140

Funding Insights of Lactose India

  • Total Rounds 1

All 1 funding rounds of Lactose India with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2017Debt – Conventional––
–

Board of directors of Lactose (India) Limited (Lactose India)

Lactose (India) Limited is the primary company behind Lactose India. The board of Lactose (India) Limited currently have 5 directors; the longest-serving is Atul Maheshwari, appointed in 1991. 14 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Atul Maheshwari
DIN 00255202
Managing Director11 Mar 199135 yrs 7 moLactose (India) Limited
Sangita Maheshwari
DIN 00369898
Whole-time director24 Jan 201412 yrs 9 moLactose (India) Limited
Nandan Srinath
DIN 08184159
Director08 Aug 20242 yrs 3 moLactose (India) Limited
Chandra Mohan Bhagavatula
DIN 09612261
Director08 Aug 20242 yrs 3 moLactose (India) Limited
Kishor Jivanbhai Patel
DIN 00740301
Director22 Aug 20251 yr 2 moLactose (India) Limited

People of Lactose India

1 people are tracked at Lactose India (1 in leadership); the tracked headcount is 140.

NameRoleGroup
Atul Maheshwari
Managing DirectorLeadership
Premium access

Complete people profiles for Lactose India

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Lactose India

Lactose India is a publicly listed company on the BSE with ticker symbol LACTOSE in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date19 Jul 2007
  • Listed onBSE: 524202
  • Listed entityLactose India Ltd.
  • Exchange sectorHealth technology
  • ISININE058I01013
  • Share price₹103.35 (-1.05% on the day) · 2026-10-14
  • Market capitalisation₹131 Cr
  • Price to earnings19.1
  • EPS (diluted, trailing year)₹5.41
  • Volume (last session)5,446

Financials of Lactose India

Exchange-reported figures of Lactose (India) Limited, the listed company behind Lactose India (BSE: LACTOSE).

Financial Highlights

FY 2025-26 · Standalone
Revenue
₹163 Cr
+40.3% YoY
EBITDA
₹18.38 Cr
+8.4% YoY
Profit After Tax
₹6.06 Cr
+18.1% YoY
Net Worth
₹64.80 Cr
+10.3% YoY
Total Assets
₹129 Cr
+10.1% YoY
Total Debt
₹62.45 Cr
+9.9% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue16311611465.8045.9434.9640.05
Revenue growth+40.3%+2.2%+73.1%+43.2%+31.4%-12.7%-
EBITDA18.3816.9619.0111.3812.276.239.26
EBITDA margin+11.3%+14.6%+16.7%+17.3%+26.7%+17.8%+23.1%
Profit before tax8.626.929.661.463.17(3.27)0.09
Net profit6.065.136.771.182.42(2.48)0.06
Net profit margin+3.7%+4.4%+5.9%+1.8%+5.3%-7.1%+0.2%
EPS (₹)4.684.105.390.961.95(2.17)0.07
Balance sheet
Total assets12911787.8279.9681.5682.8275.85
Net worth64.8058.7547.1040.5639.2935.0934.29
Total debt62.4556.8339.2538.4641.3346.1439.44
Cash & bank0.744.931.860.922.082.661.88
Net working capital47.9343.3324.4416.7614.6814.6312.93
Cash flow
Cash from operations5.56(0.29)8.757.898.472.167.41
Cash from investing(10.22)(15.57)(2.08)(0.92)(0.56)(6.18)(2.88)
Cash from financing0.7118.81(5.72)(8.32)(8.14)4.52(3.57)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue46.9745.7736.7741.1839.5827.7728.7230.45
Revenue growth (YoY)+18.7%+64.8%+28.0%+35.2%+34.4%---
Other income0.560.220.630.370.410.370.560.30
Total expenses40.8940.7433.7035.9235.1124.3625.7525.43
EBITDA6.085.033.075.264.473.412.975.02
EBITDA margin+12.9%+11.0%+8.3%+12.8%+11.3%+12.3%+10.3%+16.5%
Depreciation1.641.501.431.441.371.391.351.33
Interest1.761.431.391.041.221.841.641.37
Profit before tax3.242.320.883.152.290.550.542.62
Tax0.870.430.350.980.79(0.10)0.320.58

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 09 Nov 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue46.9745.7736.7741.1839.5827.7728.7230.45
Revenue growth (YoY)+18.7%+64.8%+28.0%+35.2%+34.4%---
Other income0.560.220.630.370.410.370.560.30
Total expenses40.8940.7433.7035.9235.1124.3625.7525.43
EBITDA6.085.033.075.264.473.412.975.02
EBITDA margin+12.9%+11.0%+8.3%+12.8%+11.3%+12.3%+10.3%+16.5%
Depreciation1.641.501.431.441.371.391.351.33
Interest1.761.431.391.041.221.841.641.37
Profit before tax3.242.320.883.152.290.550.542.62
Tax0.870.430.350.980.79(0.10)0.320.58
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue16311611465.8045.9434.9640.05
Revenue growth+40.3%+2.2%+73.1%+43.2%+31.4%-12.7%-
Other income1.071.451.120.720.580.310.30
Total expenses14599.4494.8854.4233.6728.7330.79
Employee cost0.0010.508.726.5712.2510.6311.88
EBITDA18.3816.9619.0111.3812.276.239.26
EBITDA margin+11.3%+14.6%+16.7%+17.3%+26.7%+17.8%+23.1%
Depreciation5.745.395.224.694.564.363.91
Interest5.096.105.255.955.125.455.56
Profit before tax8.626.929.661.463.17(3.27)0.09
Tax2.561.762.880.260.72(0.79)0.03
Net profit6.065.136.771.182.42(2.48)0.06
Net profit margin+3.7%+4.4%+5.9%+1.8%+5.3%-7.1%+0.2%
EPS (₹)4.684.105.390.961.95(2.17)0.07
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital12.5912.5912.5912.5912.5911.4410.19
Reserves & surplus45.6839.6334.5127.9726.7023.0524.10
Shareholders' funds (net worth)64.8058.7547.1040.5639.2935.0934.29
Secured loans60.0956.1938.0738.3040.9642.8838.55
Unsecured loans2.360.641.180.160.373.260.89
Total debt62.4556.8339.2538.4641.3346.1439.44
Total liabilities12911787.8279.9681.5682.8275.85
Assets
Gross block10987.9285.3082.2681.1177.7175.82
Net block69.1152.3254.6656.0759.2159.4761.82
Capital work in progress0.2710.240.000.000.003.520.23
Investments0.000.000.000.000.740.680.07
Inventories55.9524.5516.7922.787.128.328.91
Sundry debtors33.4621.6415.4012.4911.356.436.98
Cash & bank balances0.744.931.860.922.082.661.88
Loans & advances8.486.201.401.222.202.292.04
Total current assets98.6357.3235.4537.4122.7519.7019.81
Total current liabilities50.7013.9911.0120.658.075.076.88
Net working capital47.9343.3324.4416.7614.6814.6312.93
Total assets12911787.8279.9681.5682.8275.85
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash4.481.530.581.922.161.650.69
Net cash from operating activities5.56(0.29)8.757.898.472.167.41
Net cash from investing activities(10.22)(15.57)(2.08)(0.92)(0.56)(6.18)(2.88)
Net cash from financing activities0.7118.81(5.72)(8.32)(8.14)4.52(3.57)
Net change in cash(3.95)2.950.95(1.34)(0.24)0.510.96
Closing cash0.744.931.860.922.082.661.88
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+40.3%+2.2%+73.1%+43.2%+31.4%-12.7%-
EBITDA growth+8.4%-10.8%+67.1%-7.3%+97.0%-32.7%-
PBT growth+24.6%-28.4%+561.6%-53.9%+9998.0%--91.7%
Net income growth+18.1%-24.2%+473.7%-51.2%+197.6%-4233.3%-
Revenue CAGR (3Y)+35.4%+36.3%+48.2%+18.0%+4.2%+4.0%+4.0%
EBITDA CAGR (3Y)+17.3%+11.4%+45.0%+7.1%+8.5%+3.5%-6.6%
Profitability & leverage
Net income margin+3.7%+4.4%+6.0%+1.8%+5.3%-7.1%+0.2%
Return on capital employed-+12.7%+17.8%+9.2%+10.1%+2.8%+7.6%
Return on net worth-+9.8%+15.5%+3.0%+6.6%-7.2%+0.2%
Debt / equity-0.910.891.001.181.231.10
Long-term debt / equity-0.480.660.841.001.070.97
Interest cover40.2752.7238.0788.9466.41291.44103.93
Efficiency & per share
Fixed asset turnover-1.341.360.810.580.460.55
Inventory turnover-5.635.764.405.954.064.71
Debtors turnover-6.298.175.525.175.215.78
EPS (₹)4.684.105.390.961.95(2.17)0.07
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)0.0041.4837.4132.2231.2130.1533.65

Timeline of Lactose India

3 dated milestones of Lactose India across 26 years, from founding to its latest funding, stage changes and deals.

  1. Founded Lactose India is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Funding First funding round.

Web traffic of Lactose India

The website of Lactose India (lactoseindialimited.com) receives about 1.4K visits a month.

  • Monthly visits
    1.4K

    ▲ 43.2% vs previous month

Top companies in Nutraceutical & Food-as-Medicine Platforms

3 companies that operate in the same segment as Lactose India (Nutraceutical & Food-as-Medicine Platforms) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Kapiva
Ayurvedic healthcare and nutritional products are provided by Kapiva.
2016Bengaluru, Karnataka, IndiaUSD 77.85 MUSD 55.41 M362
OmniActive
Nutritional supplements for multiple health ailments are developed.
2005Mumbai, Maharashtra, IndiaUSD 1.55 M
OZiva
Nutritional food and health supplements are provided by OZiva.
2010Mumbai, Maharashtra, IndiaUSD 17.32 MUSD 56.21 M144
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Lactose India

Lactose (India) standalone net profit declines 71.88% in the September 2022 quarter
India Infoline • 1 year ago
Lactose (India) to hold board meeting
India Infoline • 1 year ago
Lactose (India) Approved Issue Of Convertible Share Warrants On Preferential Basis
Reuters • 1 year ago
Lactose (India) Approves Issue Of 1.5 Mln Convertible Warrants To Sg General Dealers Llp
Reuters • 2 years ago
Lactose India To Avail Term Loan From Aditya Birla Finance Capital Upto 10% Of Outstanding Loan
Reuters • 4 years ago
Lactose India Chairperson Shyamsunder Toshniwal Steps Down
Reuters • 4 years ago
Lactose India gets nod to avail loan up to Rs 50 crore
Udaipurkiran • 7 years ago
Premium access

Complete news archive for Lactose India

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lactose India

Lactose India was founded in 1991 and raised its 1st funding round 26 years after it was founded.

Lactose India is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.

Lactose India has 140 employees.

The primary company behind Lactose India, Lactose (India) Limited, reported revenue of ₹164 Cr for FY 2026, up 40% year on year.

The company was founded in 1991 in Ahmedabad, India, and operates within the pharmaceutical sector. Excipients such as lactose monohydrate and lactulose are produced, alongside solid and liquid dosage forms. Manufacturing and supply chain services are provided in compliance with regulatory standards. Research and development efforts are focused on pharmaceutical innovations, while partnerships are maintained to support industry advancements.

Yes, Lactose India is publicly traded on BSE under the ticker symbol LACTOSE.

Lactose India operates through Lactose (India) Limited.

The legal entities of Lactose India currently have 6 directors, including Atul Maheshwari, Sangita Maheshwari, Ritesh Pandey and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available